Cargando…
Common variants in glyoxalase I do not increase chronic pancreatitis risk
INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818803/ https://www.ncbi.nlm.nih.gov/pubmed/31661534 http://dx.doi.org/10.1371/journal.pone.0222927 |
_version_ | 1783463653196955648 |
---|---|
author | Kaune, Tom Hollenbach, Marcus Keil, Bettina Chen, Jian-Min Masson, Emmanuelle Becker, Carla Damm, Marko Ruffert, Claudia Grützmann, Robert Hoffmeister, Albrecht te Morsche, Rene H. M. Cavestro, Giulia Martina Zuppardo, Raffaella Alessia Saftoiu, Adrian Malecka-Panas, Ewa Głuszek, Stanislaw Bugert, Peter Lerch, Markus M. Weiss, Frank Ulrich Zou, Wen-Bin Liao, Zhuan Hegyi, Peter Drenth, Joost PH Riedel, Jan Férec, Claude Scholz, Markus Kirsten, Holger Tóth, Andrea Ewers, Maren Witt, Heiko Griesmann, Heidi Michl, Patrick Rosendahl, Jonas |
author_facet | Kaune, Tom Hollenbach, Marcus Keil, Bettina Chen, Jian-Min Masson, Emmanuelle Becker, Carla Damm, Marko Ruffert, Claudia Grützmann, Robert Hoffmeister, Albrecht te Morsche, Rene H. M. Cavestro, Giulia Martina Zuppardo, Raffaella Alessia Saftoiu, Adrian Malecka-Panas, Ewa Głuszek, Stanislaw Bugert, Peter Lerch, Markus M. Weiss, Frank Ulrich Zou, Wen-Bin Liao, Zhuan Hegyi, Peter Drenth, Joost PH Riedel, Jan Férec, Claude Scholz, Markus Kirsten, Holger Tóth, Andrea Ewers, Maren Witt, Heiko Griesmann, Heidi Michl, Patrick Rosendahl, Jonas |
author_sort | Kaune, Tom |
collection | PubMed |
description | INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP). METHODS: Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples. RESULTS: In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961–1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985–1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673–1.124; France, p = 0.19, OR 0.90, 95% CI 0.76–1.06; China, p = 0.24, OR 1.18, 95% CI 0.90–1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750–1.087). CONCLUSIONS: Common GLO1 variants do not increase chronic pancreatitis risk. |
format | Online Article Text |
id | pubmed-6818803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-68188032019-11-01 Common variants in glyoxalase I do not increase chronic pancreatitis risk Kaune, Tom Hollenbach, Marcus Keil, Bettina Chen, Jian-Min Masson, Emmanuelle Becker, Carla Damm, Marko Ruffert, Claudia Grützmann, Robert Hoffmeister, Albrecht te Morsche, Rene H. M. Cavestro, Giulia Martina Zuppardo, Raffaella Alessia Saftoiu, Adrian Malecka-Panas, Ewa Głuszek, Stanislaw Bugert, Peter Lerch, Markus M. Weiss, Frank Ulrich Zou, Wen-Bin Liao, Zhuan Hegyi, Peter Drenth, Joost PH Riedel, Jan Férec, Claude Scholz, Markus Kirsten, Holger Tóth, Andrea Ewers, Maren Witt, Heiko Griesmann, Heidi Michl, Patrick Rosendahl, Jonas PLoS One Research Article INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP). METHODS: Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples. RESULTS: In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961–1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985–1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673–1.124; France, p = 0.19, OR 0.90, 95% CI 0.76–1.06; China, p = 0.24, OR 1.18, 95% CI 0.90–1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750–1.087). CONCLUSIONS: Common GLO1 variants do not increase chronic pancreatitis risk. Public Library of Science 2019-10-29 /pmc/articles/PMC6818803/ /pubmed/31661534 http://dx.doi.org/10.1371/journal.pone.0222927 Text en © 2019 Kaune et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kaune, Tom Hollenbach, Marcus Keil, Bettina Chen, Jian-Min Masson, Emmanuelle Becker, Carla Damm, Marko Ruffert, Claudia Grützmann, Robert Hoffmeister, Albrecht te Morsche, Rene H. M. Cavestro, Giulia Martina Zuppardo, Raffaella Alessia Saftoiu, Adrian Malecka-Panas, Ewa Głuszek, Stanislaw Bugert, Peter Lerch, Markus M. Weiss, Frank Ulrich Zou, Wen-Bin Liao, Zhuan Hegyi, Peter Drenth, Joost PH Riedel, Jan Férec, Claude Scholz, Markus Kirsten, Holger Tóth, Andrea Ewers, Maren Witt, Heiko Griesmann, Heidi Michl, Patrick Rosendahl, Jonas Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title | Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title_full | Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title_fullStr | Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title_full_unstemmed | Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title_short | Common variants in glyoxalase I do not increase chronic pancreatitis risk |
title_sort | common variants in glyoxalase i do not increase chronic pancreatitis risk |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818803/ https://www.ncbi.nlm.nih.gov/pubmed/31661534 http://dx.doi.org/10.1371/journal.pone.0222927 |
work_keys_str_mv | AT kaunetom commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT hollenbachmarcus commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT keilbettina commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT chenjianmin commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT massonemmanuelle commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT beckercarla commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT dammmarko commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT ruffertclaudia commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT grutzmannrobert commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT hoffmeisteralbrecht commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT temorscherenehm commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT cavestrogiuliamartina commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT zuppardoraffaellaalessia commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT saftoiuadrian commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT maleckapanasewa commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT głuszekstanislaw commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT bugertpeter commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT lerchmarkusm commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT weissfrankulrich commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT zouwenbin commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT liaozhuan commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT hegyipeter commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT drenthjoostph commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT riedeljan commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT ferecclaude commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT scholzmarkus commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT kirstenholger commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT tothandrea commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT ewersmaren commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT wittheiko commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT griesmannheidi commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT michlpatrick commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk AT rosendahljonas commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk |